National Research Corporation EV/EBITDA Ratio 2011-2026 | NRC

Annual EV/EBITDA Ratio National Research Corporation

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
21	22.9	35.8	26.7	22.3	10.9	10.8	9.46	12.7	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
35.8	9.46	19.2

EV/EBITDA Ratio of other stocks in the Diagnostics research industry

Issuer	EV/EBITDA Ratio	Price	% 24h	Market Cap	Country
Agilent Technologies A	27.4	$ 110.24	-2.86 %	$ 33.5 B	USA
Centogene N.V. CNTG	0.387	-	-6.23 %	$ 30.6 M	Germany
Waters Corporation WAT	24.6	$ 289.16	-3.79 %	$ 17.2 B	USA
Exagen XGN	-2.2	$ 2.68	-3.94 %	$ 57.8 M	USA
Enzo Biochem ENZ	58.3	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	-20.8	-	-	$ 19.8 B	USA
Akumin AKU	28.1	-	-17.87 %	$ 25.9 M	Canada
Burning Rock Biotech Limited BNR	-1.51	$ 16.36	-11.57 %	$ 176 M	China
Sotera Health Company SHC	24.8	$ 13.13	-3.03 %	$ 3.73 B	USA
Check-Cap Ltd. CHEK	-0.674	-	-	$ 9.42 M	Israel
Heska Corporation HSKA	141	-	-	$ 1.31 B	USA
Oxford Immunotec Global PLC OXFD	-73.4	-	-	$ 562 M	Britain
BioNano Genomics BNGO	-7.71	$ 1.16	0.87 %	$ 6.32 M	USA
DermTech DMTK	-2.44	-	-11.32 %	$ 2.94 M	USA
Aspira Women's Health AWH	-2.63	-	-6.19 %	$ 10.5 M	USA
DexCom DXCM	39.5	$ 62.25	-5.81 %	$ 24.3 B	USA
Accelerate Diagnostics AXDX	-5.56	-	-61.36 %	$ 2.46 M	USA
Global Cord Blood Corporation CO	-3.52	-	-	$ 399 M	China
Fluidigm Corporation FLDM	-13.6	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	-2.67	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-2.67	-	0.12 %	$ 80.1 M	China
HTG Molecular Diagnostics HTGM	-1.42	-	-20.0 %	$ 1.06 M	USA
Castle Biosciences CSTL	-21.2	$ 23.53	-4.74 %	$ 654 M	USA
PRA Health Sciences, Inc. PRAH	20.8	-	-	$ 10.7 B	USA
Charles River Laboratories International CRL	22	$ 159.16	-3.62 %	$ 7.89 B	USA
Quest Diagnostics Incorporated DGX	5.51	$ 195.51	-1.33 %	$ 21.7 B	USA
Organovo Holdings ONVO	0.992	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	0.274	-	-16.95 %	$ 1.54 M	USA
Biocept BIOC	-26.9	-	-13.05 %	$ 7.29 M	USA
PerkinElmer PKI	18.8	-	-0.91 %	$ 14.7 B	USA
Invitae Corporation NVTA	-10.7	-	-	$ 21.2 M	USA
Interpace Biosciences IDXG	-6.02	$ 1.68	-2.89 %	$ 7.37 M	USA
Motus GI Holdings MOTS	0.351	-	-34.28 %	$ 263 K	Israel
QIAGEN N.V. QGEN	13.2	-	-	$ 10.6 B	Niderland
Neogen Corporation NEOG	40.3	$ 8.7	-4.92 %	$ 1.89 B	USA
Chembio Diagnostics CEMI	-1.23	-	0.22 %	$ 16.8 M	USA
Laboratory Corporation of America Holdings LH	8.7	$ 264.2	-1.56 %	$ 22 B	USA
Psychemedics Corporation PMD	15.9	-	-1.84 %	$ 15.3 M	USA
Precipio PRPO	-1.8	$ 25.97	-4.52 %	$ 33.7 M	USA
CareDx, Inc CDNA	-100	$ 16.78	-3.95 %	$ 894 M	USA
Quotient Limited QTNT	-5.32	-	-11.32 %	$ 1.1 M	Schweiz
Syneos Health SYNH	22.5	-	-	$ 4.46 B	USA
Renalytix AI plc RNLX	-32.1	-	5.66 %	$ 22.7 M	Britain
VolitionRx Limited VNRX	-3.45	$ 0.2	1.87 %	$ 19.2 M	Singapore
Bioventus BVS	26.4	$ 8.94	-3.46 %	$ 596 M	USA
Co-Diagnostics CODX	3.62	$ 4.4	101.83 %	$ 129 M	USA
Meridian Bioscience VIVO	7.53	-	-	$ 1.49 B	USA
Danaher Corporation DHR	20.1	$ 181.52	-3.27 %	$ 129 B	USA
Surmodics SRDX	42.7	-	-	$ 608 M	USA
ENDRA Life Sciences NDRA	0.831	$ 4.29	-6.54 %	$ 2.3 M	USA